Wanbang Biopharmaceuticals Co.,Ltd.
Exhibitor at CPhI South East Asia 2019 stand P11
Wanbang Biopharmaceuticals Co Ltd focuses on developing, manufacturing, and selling pharmaceuticals for patients of diabetes and related cardiovascular diseases. Its products include animal insulin, Glimepiride tablets, Meglumine Adenosine Cyclophosphate, EPO, Bangtan (Telmisatan), and Heparin sodium. The company's products also comprise aloe compound capsules for clearing liver-heat, relaxing bowels, and calming heart for tranquillization; and products in the fields of chemicals, pharmaceuticals, and biotech, such as Human Interferon, Human Erythropoietin, Streptokinase, and Pemetrexed disodium. It sells products through a network of distributors and sales representatives in China and internationally. The company was founded in 1981 and is based in Xuzhou, China. Wanbang Biopharmaceuticals Co Ltd operates as a subsidiary of Shanghai FOSUN Pharmaceutical (Group) Co Ltd.
Specs about this supplier
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Affiliated categories:||Capsules More|
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation